Abstract
Clostridium botulinum neurotoxins (BoNTs) cleave neuronal proteins responsible for neurotransmitter release, causing the neuroparalytic disease botulism. BoNT serotypes B, D, F and G cleave and inactivate vesicle-associated membrane protein (VAMP), each at a unique peptide bond. The specificity of BoNTs depends on the mode of substrate recognition. We have investigated the mechanism of substrate recognition of BoNT F by determining the crystal structures of its complex with two substrate-based inhibitors, VAMP 22-58/Gln58D-cysteine and 27-58/Gln58D-cysteine. The inhibitors bind to BoNT F in the canonical direction (as seen for BoNTs A and E substrates) but are positioned specifically via three major exosites away from the active site. The cysteine sulfur of the inhibitors interacts with the zinc and exists as sulfinic acid in the inhibitor VAMP 27-58/Gln58D-cysteine. Arg133 and Arg171, which form part of two separate exosites, are crucial for substrate binding and catalysis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Montecucco, C. & Schiavo, G. Mechanism of action of tetanus and botulinum neurotoxins. Mol. Microbiol. 13, 1–8 (1994).
Schiavo, G., Matteoli, M. & Montecucco, C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80, 717–766 (2000).
Kurazono, H. et al. Minimal essential domains specifying toxicity of the light chains of tetanus toxin and botulinum neurotoxin type A. J. Biol. Chem. 267, 14721–14729 (1992).
Lebeda, F.J. & Olson, M.A. Structural predictions of the channel-forming region of botulinum neurotoxin heavy chain. Toxicon 33, 559–567 (1995).
Agarwal, R. & Swaminathan, S. SNAP-25 substrate peptide (residues 180–183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E. J. Biol. Chem. 283, 25944–25951 (2008).
Breidenbach, M.A. & Brunger, A. Substrate recognition strategy for botulinum neurotoxin serotype A. Nature 432, 925–929 (2004).
Kumaran, D., Rawat, R., Ahmed, S.A. & Swaminathan, S. Substrate binding mode and its implication on drug design for botulinum neurotoxin A. PLoS Pathog. 4, e1000165 (2008).
Hanson, M.A. & Stevens, R.C. Cocrystal structure of synaptobrevin-ll bound to botulinum neurotoxin type B at 2.0 Å resolution. Nat. Struct. Biol. 7, 687–692 (2000).
Rupp, B. & Segelke, B. Questions about the structure of the botulinum neurotoxin B light chain in complex with a target peptide. Nat. Struct. Biol. 8, 663–664 (2001).
Schmidt, J.J. & Stafford, R.G. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity. Biochemistry 44, 4067–4073 (2005).
Agarwal, R., Binz, T. & Swaminathan, S. Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design. Biochemistry 44, 11758–11765 (2005).
Sikorra, S., Henke, T., Galli, T. & Binz, T. Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins. J. Biol. Chem. 283, 21145–21152 (2008).
Pellizzari, R., Mason, S., Shone, C.C. & Montecucco, C. The interaction of synaptic vesicle-associated membrane protein/synaptobrevin with botulinum neurotoxins D and F. FEBS Lett. 409, 339–342 (1997).
Silvaggi, N.R., Wilson, D., Tzipori, S. & Allen, K.N. Catalytic features of the botulinum neurotoxin A light chain revealed by high resolution structure of an inhibitory peptide complex. Biochemistry 47, 5736–5745 (2008).
Chen, S. & Barbieri, J.T. Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E. J. Biol. Chem. 282, 25540–25547 (2007).
Studier, F.W. Protein production by auto-induction in high-density shaking cultures. Protein Expr. Purif. 41, 207–234 (2005).
Agarwal, R., Eswaramoorthy, S., Kumaran, D., Dunn, J.J. & Swaminathan, S. Cloning, high level expression, purification and crystallization of the full length Clostridium botulinum neurotoxin type E light chain. Protein Expr. Purif. 34, 95–102 (2004).
Vagin, A. & Teplyakov, A. An approach to multi-copy search in molecular replacement. Acta Crystallogr. D 56, 1622–1624 (2000).
Brunger, A.T. et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905–921 (1998).
Jones, T.A., Zou, J.-Y., Cowan, S.W. & Kjeldgaard, M. Improved methods in building protein models in electron density map and the location of errors in these models. Acta Crystallogr. A 47, 110–119 (1991).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
Acknowledgements
Research was supported by award from the US Defense Threat Reduction Agency (DTRA) BO742081 under Department of Energy prime contract N0. DEAC02-98CH10886 with Brookhaven National Laboratory (BNL) (to S.S.). It was also funded in part by the DTRA under research plan 3.10023_06_RD_B (J.J.S. and R.G.S.). Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the US Army. We gratefully acknowledge the data collection support from X12c and X29 (National Synchrotron Light Source). We thank M.G. Blewitt for DNA sequencing of mutants, the Proteomic Center of Stony Brook University for their help with MALDI-TOF measurements and V. Graziano (BNL) for help in tryptophan florescence experiments and discussion.
Author information
Authors and Affiliations
Contributions
R.A. performed the experiments; S.S. conceived and designed the experiments; R.A., S.S. and J.J.S. wrote the manuscript; R.G.S. and J.J.S. designed the inhibitors.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–8 and Supplementary Discussion (PDF 1054 kb)
Rights and permissions
About this article
Cite this article
Agarwal, R., Schmidt, J., Stafford, R. et al. Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F. Nat Struct Mol Biol 16, 789–794 (2009). https://doi.org/10.1038/nsmb.1626
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb.1626
This article is cited by
-
A DARPin promotes faster onset of botulinum neurotoxin A1 action
Nature Communications (2023)
-
Structural characterisation of the catalytic domain of botulinum neurotoxin X - high activity and unique substrate specificity
Scientific Reports (2018)
-
Structural analysis of Clostridium botulinum neurotoxin type D as a platform for the development of targeted secretion inhibitors
Scientific Reports (2015)
-
The blockade of the neurotransmitter release apparatus by botulinum neurotoxins
Cellular and Molecular Life Sciences (2014)